Skip to content

This site is intended for healthcare professionals in the UK only. Prescribing information and Adverse Event (AE) reporting details can be found in the footer.

  • Why Zegluxen®
    • Therapeutic indications
    • Clinical efficacy
    • Mechanism of action
    • Patient eligibility
  • Cost savings
  • How to Administer
    • Dose Titration
    • Storage and shelf life
    • Method of administration
  • Safety & Tolerability
    • Possible side effects
    • Special warnings and precautions for use
    • Special populations
    • Drug interactions
  • Supporting information
    • FAQs
  • Why Zegluxen®
    • Therapeutic indications
    • Clinical efficacy
    • Mechanism of action
    • Patient eligibility
  • Cost savings
  • How to Administer
    • Dose Titration
    • Storage and shelf life
    • Method of administration
  • Safety & Tolerability
    • Possible side effects
    • Special warnings and precautions for use
    • Special populations
    • Drug interactions
  • Supporting information
    • FAQs

Cost savings

Zentiva aims to have the lowest acquisition costs at all times and constantly monitors prices within the UK to ensure we remain competitive

Two Zegluxen packs side-by-side

Zentiva aims to have the lowest acquisition costs at all times and constantly monitors prices within the UK to ensure we remain competitive

Zegluxen®  provides a cost effective and clinically comparable liraglutide treatment for diabetes, with the additional benefit of comprehensive HCP and patient support. See SmPC for full indication.1

 

Product PIP code Pack size Zegluxen NHS list price2 EAN code
Zegluxen 6mg/ml pre-filled pen 429-3007 2 £50.49 8594739305465
Zegluxen 6mg/ml pre-filled pen 429-3015 3 £76.52 8594739305434

 

  1. https://dmd-browser.nhsbsa.nhs.uk/search/results?ampName=zegluxen&searchType=AMP&showInvalidItems=false&hideParallelImport=false&hideSpecialOrder=false&hideDiscontinuedItems=false
  2. https://www.drugtariff.nhsbsa.nhs.uk/#/00871516-DC/DC00871512/Home

 

000772140 | August 2025

Prescribing information can be found here

  • Navigation
    • Terms of Use
    • HCP Privacy
    • Cookies Policy
    • GDPR

MORE ABOUT US

linkedin

Reporting of side effects

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Zentiva Pharma UK Ltd via our online form (https://www.zentiva.co.uk/contact/mi-form), by email (UKMedInfo@zentiva.com) or by telephone (0800 090 2408).

Copyright Zentiva Group, a.s. © 2025

I confirm I am a UK Healthcare Professional (HCP)

This page is dedicated to UK HCPs only. If you are not a UK HCP, you will be directed to the gateway page after clicking on No.

No, I am not Yes, I am